IMMUNIC, INC. — Director's Dealing 2019

Apr 22, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: IMMUNIC, INC. (IMUX)
CIK: 0001280776
Period of Report: 2019-04-12

Reporting Person: Global Life Bioventure V Sarl (10% Owner)
Reporting Person: Omega Fund V, L.P. (10% Owner)
Reporting Person: Omega Fund V GP, L.P. (10% Owner)
Reporting Person: Omega Fund V GP Manager, Ltd. (10% Owner)
Reporting Person: Lim Richard J. (10% Owner)
Reporting Person: Stampacchia Otello (10% Owner)
Reporting Person: Nessi Claudio (10% Owner)
Reporting Person: Paster Anne-Mari (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1371494	Indirect

Footnotes

F1: On April 12, 2019, pursuant to an Exchange Agreement, dated as of January 6, 2019, between the Issuer (then known as Vital Therapies, Inc.), Immunic AG ("Immunic"), and the shareholders of Immunic party thereto (the "Exchange Agreement"), the holders of Immunic ordinary shares exchanged all of their outstanding shares for shares of Issuer common stock, resulting in Immunic becoming a wholly-owned subsidiary of the Issuer (the "Transaction"). Immediately following the Transaction, the Issuer changed its name to "Immunic, Inc." In connection with the Transaction, the Reporting Person received shares of common stock of the Issuer.

F2: The reported securities are held directly by Global Life Bioventure V S.a r.l. ("Global Life"). The reported securities may be deemed to be beneficially owned by each of Omega Fund V, L.P. ("Omega V"), the sole owner of Global Life, Omega Fund V GP, L.P. ("Omega V GP"), as the general partner of Omega V, and Omega Fund V GP Manager, Ltd. ("Omega V GP Manager"), as the general partner of Omega V GP. Otello Stampacchia, Richard Lim, Anne-Mari Paster and Claudio Nessi (the "Omega Directors") are all the shareholders and directors of Omega V GP Manager and have shared voting and investment power over the shares held by Omega V. Each of Omega V GP, Omega Fund V GP Manager and the Omega Directors disclaims beneficial ownership of the securities reported herein, except to the extent of its or their pecuniary interest therein, if any.